nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—skin epidermis—atopic dermatitis	0.0378	0.343	CbGeAlD
Ingenol Mebutate—Application site warmth—Tacrolimus—atopic dermatitis	0.0369	0.0668	CcSEcCtD
Ingenol Mebutate—Application site paraesthesia—Tacrolimus—atopic dermatitis	0.0369	0.0668	CcSEcCtD
Ingenol Mebutate—Application site burn—Desonide—atopic dermatitis	0.033	0.0597	CcSEcCtD
Ingenol Mebutate—Application site erythema—Desonide—atopic dermatitis	0.0294	0.0531	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Desonide—atopic dermatitis	0.0284	0.0512	CcSEcCtD
Ingenol Mebutate—Application site burn—Fluocinonide—atopic dermatitis	0.0268	0.0484	CcSEcCtD
Ingenol Mebutate—Application site irritation—Desonide—atopic dermatitis	0.0249	0.0451	CcSEcCtD
Ingenol Mebutate—Application site burn—Pimecrolimus—atopic dermatitis	0.0233	0.0422	CcSEcCtD
Ingenol Mebutate—PRKCD—skin of body—atopic dermatitis	0.0212	0.193	CbGeAlD
Ingenol Mebutate—Application site erythema—Pimecrolimus—atopic dermatitis	0.0208	0.0375	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Pimecrolimus—atopic dermatitis	0.02	0.0362	CcSEcCtD
Ingenol Mebutate—PRKCA—neck—atopic dermatitis	0.0181	0.164	CbGeAlD
Ingenol Mebutate—Application site irritation—Pimecrolimus—atopic dermatitis	0.0176	0.0318	CcSEcCtD
Ingenol Mebutate—Application site pain—Desonide—atopic dermatitis	0.0157	0.0284	CcSEcCtD
Ingenol Mebutate—PRKCD—head—atopic dermatitis	0.0138	0.126	CbGeAlD
Ingenol Mebutate—Application site pain—Fluocinonide—atopic dermatitis	0.0128	0.023	CcSEcCtD
Ingenol Mebutate—Application site burn—Tacrolimus—atopic dermatitis	0.0127	0.0229	CcSEcCtD
Ingenol Mebutate—PRKCA—skin of body—atopic dermatitis	0.0117	0.106	CbGeAlD
Ingenol Mebutate—Application site erythema—Tacrolimus—atopic dermatitis	0.0113	0.0204	CcSEcCtD
Ingenol Mebutate—Application site pain—Pimecrolimus—atopic dermatitis	0.0111	0.0201	CcSEcCtD
Ingenol Mebutate—Application site pruritus—Tacrolimus—atopic dermatitis	0.0109	0.0197	CcSEcCtD
Ingenol Mebutate—Application site irritation—Tacrolimus—atopic dermatitis	0.00958	0.0173	CcSEcCtD
Ingenol Mebutate—Instillation site pain—Tacrolimus—atopic dermatitis	0.00816	0.0148	CcSEcCtD
Ingenol Mebutate—Application site burn—Hydrocortisone—atopic dermatitis	0.00792	0.0143	CcSEcCtD
Ingenol Mebutate—PRKCA—head—atopic dermatitis	0.00763	0.0693	CbGeAlD
Ingenol Mebutate—Eyelid oedema—Fluocinolone Acetonide—atopic dermatitis	0.00694	0.0125	CcSEcCtD
Ingenol Mebutate—Application site pain—Tacrolimus—atopic dermatitis	0.00605	0.0109	CcSEcCtD
Ingenol Mebutate—Application site irritation—Hydrocortisone—atopic dermatitis	0.00598	0.0108	CcSEcCtD
Ingenol Mebutate—Swelling—Fluocinonide—atopic dermatitis	0.00461	0.00834	CcSEcCtD
Ingenol Mebutate—Swelling—Pimecrolimus—atopic dermatitis	0.00402	0.00727	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Desonide—atopic dermatitis	0.00387	0.007	CcSEcCtD
Ingenol Mebutate—Infestation—Desonide—atopic dermatitis	0.00387	0.007	CcSEcCtD
Ingenol Mebutate—Application site pain—Hydrocortisone—atopic dermatitis	0.00377	0.00682	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluocinonide—atopic dermatitis	0.00364	0.00658	CcSEcCtD
Ingenol Mebutate—Ulcer—Mometasone—atopic dermatitis	0.00353	0.00639	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Pimecrolimus—atopic dermatitis	0.00317	0.00574	CcSEcCtD
Ingenol Mebutate—Erythema—Desonide—atopic dermatitis	0.00303	0.00547	CcSEcCtD
Ingenol Mebutate—Eye pain—Fluocinolone Acetonide—atopic dermatitis	0.00281	0.00509	CcSEcCtD
Ingenol Mebutate—Ulcer—Tacrolimus—atopic dermatitis	0.00281	0.00508	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Pimecrolimus—atopic dermatitis	0.00274	0.00494	CcSEcCtD
Ingenol Mebutate—Infestation—Pimecrolimus—atopic dermatitis	0.00274	0.00494	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Pimecrolimus—atopic dermatitis	0.00266	0.00481	CcSEcCtD
Ingenol Mebutate—Infection—Desonide—atopic dermatitis	0.00245	0.00443	CcSEcCtD
Ingenol Mebutate—Erythema—Fluocinonide—atopic dermatitis	0.00245	0.00443	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Desonide—atopic dermatitis	0.00242	0.00438	CcSEcCtD
Ingenol Mebutate—Eye disorder—Pimecrolimus—atopic dermatitis	0.00229	0.00415	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluocinolone Acetonide—atopic dermatitis	0.00227	0.00411	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Mometasone—atopic dermatitis	0.00217	0.00392	CcSEcCtD
Ingenol Mebutate—Eye pain—Tacrolimus—atopic dermatitis	0.00214	0.00387	CcSEcCtD
Ingenol Mebutate—Erythema—Pimecrolimus—atopic dermatitis	0.00214	0.00386	CcSEcCtD
Ingenol Mebutate—Infection—Fluocinonide—atopic dermatitis	0.00199	0.00359	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluocinonide—atopic dermatitis	0.00196	0.00355	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Fluocinolone Acetonide—atopic dermatitis	0.00196	0.00354	CcSEcCtD
Ingenol Mebutate—Infestation—Fluocinolone Acetonide—atopic dermatitis	0.00196	0.00354	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Mometasone—atopic dermatitis	0.00182	0.00328	CcSEcCtD
Ingenol Mebutate—Infection—Pimecrolimus—atopic dermatitis	0.00173	0.00313	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00171	0.00309	CcSEcCtD
Ingenol Mebutate—Ulcer—Triamcinolone—atopic dermatitis	0.00165	0.00299	CcSEcCtD
Ingenol Mebutate—Eye disorder—Fluocinolone Acetonide—atopic dermatitis	0.00164	0.00297	CcSEcCtD
Ingenol Mebutate—Headache—Desonide—atopic dermatitis	0.00155	0.0028	CcSEcCtD
Ingenol Mebutate—Erythema—Fluocinolone Acetonide—atopic dermatitis	0.00153	0.00277	CcSEcCtD
Ingenol Mebutate—Ulcer—Betamethasone—atopic dermatitis	0.0015	0.00271	CcSEcCtD
Ingenol Mebutate—Ulcer—Dexamethasone—atopic dermatitis	0.0015	0.00271	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Tacrolimus—atopic dermatitis	0.00149	0.00269	CcSEcCtD
Ingenol Mebutate—Infestation—Tacrolimus—atopic dermatitis	0.00149	0.00269	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Tacrolimus—atopic dermatitis	0.00145	0.00261	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Loratadine—atopic dermatitis	0.00136	0.00246	CcSEcCtD
Ingenol Mebutate—Ulcer—Prednisone—atopic dermatitis	0.00131	0.00236	CcSEcCtD
Ingenol Mebutate—Headache—Fluocinonide—atopic dermatitis	0.00125	0.00227	CcSEcCtD
Ingenol Mebutate—Eye disorder—Tacrolimus—atopic dermatitis	0.00125	0.00226	CcSEcCtD
Ingenol Mebutate—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00124	0.00224	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00122	0.00221	CcSEcCtD
Ingenol Mebutate—Infection—Mometasone—atopic dermatitis	0.00118	0.00214	CcSEcCtD
Ingenol Mebutate—Erythema—Tacrolimus—atopic dermatitis	0.00116	0.0021	CcSEcCtD
Ingenol Mebutate—Eye pain—Dexamethasone—atopic dermatitis	0.00114	0.00206	CcSEcCtD
Ingenol Mebutate—Eye pain—Betamethasone—atopic dermatitis	0.00114	0.00206	CcSEcCtD
Ingenol Mebutate—Headache—Dimenhydrinate—atopic dermatitis	0.00113	0.00204	CcSEcCtD
Ingenol Mebutate—Headache—Diphenhydramine—atopic dermatitis	0.00113	0.00204	CcSEcCtD
Ingenol Mebutate—Headache—Pimecrolimus—atopic dermatitis	0.00109	0.00198	CcSEcCtD
Ingenol Mebutate—Infection—Tacrolimus—atopic dermatitis	0.000943	0.0017	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000931	0.00168	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000928	0.00168	CcSEcCtD
Ingenol Mebutate—Infestation—Hydrocortisone—atopic dermatitis	0.000928	0.00168	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Prednisolone—atopic dermatitis	0.000924	0.00167	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000872	0.00158	CcSEcCtD
Ingenol Mebutate—Infestation—Methylprednisolone—atopic dermatitis	0.000872	0.00158	CcSEcCtD
Ingenol Mebutate—Headache—Loratadine—atopic dermatitis	0.00087	0.00157	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Triamcinolone—atopic dermatitis	0.00085	0.00154	CcSEcCtD
Ingenol Mebutate—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000782	0.00141	CcSEcCtD
Ingenol Mebutate—Eye disorder—Hydrocortisone—atopic dermatitis	0.000779	0.00141	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000771	0.00139	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Betamethasone—atopic dermatitis	0.000771	0.00139	CcSEcCtD
Ingenol Mebutate—PRKCA—Endothelins—MAPK8—atopic dermatitis	0.000755	0.00224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—DEFB1—atopic dermatitis	0.000748	0.00222	CbGpPWpGaD
Ingenol Mebutate—Headache—Mometasone—atopic dermatitis	0.000747	0.00135	CcSEcCtD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL17—atopic dermatitis	0.000744	0.00221	CbGpPWpGaD
Ingenol Mebutate—Erythema—Prednisolone—atopic dermatitis	0.000743	0.00134	CcSEcCtD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—MAPK8—atopic dermatitis	0.000737	0.00219	CbGpPWpGaD
Ingenol Mebutate—Eye disorder—Methylprednisolone—atopic dermatitis	0.000732	0.00132	CcSEcCtD
Ingenol Mebutate—PRKCD—Interferon Signaling—IFNG—atopic dermatitis	0.00073	0.00217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling in naïve CD8+ T cells—MAPK8—atopic dermatitis	0.000728	0.00216	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—MAPK8—atopic dermatitis	0.000728	0.00216	CbGpPWpGaD
Ingenol Mebutate—Erythema—Hydrocortisone—atopic dermatitis	0.000725	0.00131	CcSEcCtD
Ingenol Mebutate—PRKCD—Hemostasis—IL5—atopic dermatitis	0.000706	0.0021	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	0.000698	0.00207	CbGpPWpGaD
Ingenol Mebutate—Erythema—Triamcinolone—atopic dermatitis	0.000683	0.00123	CcSEcCtD
Ingenol Mebutate—Erythema—Methylprednisolone—atopic dermatitis	0.000682	0.00123	CcSEcCtD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—MAPK8—atopic dermatitis	0.000679	0.00202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000677	0.00201	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CASP1—atopic dermatitis	0.000671	0.00199	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—GLB1—atopic dermatitis	0.000668	0.00198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cardiac Hypertrophic Response—TNF—atopic dermatitis	0.000666	0.00198	CbGpPWpGaD
Ingenol Mebutate—Eye disorder—Betamethasone—atopic dermatitis	0.000665	0.0012	CcSEcCtD
Ingenol Mebutate—Eye disorder—Dexamethasone—atopic dermatitis	0.000665	0.0012	CcSEcCtD
Ingenol Mebutate—PRKCA—Hemostasis—KIF3A—atopic dermatitis	0.000664	0.00197	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—IL1B—atopic dermatitis	0.000654	0.00194	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—MAPK8—atopic dermatitis	0.00064	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—CXCL8—atopic dermatitis	0.000634	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—TCR Signaling Pathway—IL6—atopic dermatitis	0.000631	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—NFKBIA—atopic dermatitis	0.000625	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—MAPK8—atopic dermatitis	0.000624	0.00185	CbGpPWpGaD
Ingenol Mebutate—Erythema—Dexamethasone—atopic dermatitis	0.00062	0.00112	CcSEcCtD
Ingenol Mebutate—Erythema—Betamethasone—atopic dermatitis	0.00062	0.00112	CcSEcCtD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000618	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—TLR2—atopic dermatitis	0.000606	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KIF3A—atopic dermatitis	0.000606	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—IL2—atopic dermatitis	0.000606	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL11—atopic dermatitis	0.0006	0.00178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—MAPK8—atopic dermatitis	0.0006	0.00178	CbGpPWpGaD
Ingenol Mebutate—Headache—Tacrolimus—atopic dermatitis	0.000595	0.00107	CcSEcCtD
Ingenol Mebutate—PRKCD—Signaling Pathways—FCER2—atopic dermatitis	0.000592	0.00176	CbGpPWpGaD
Ingenol Mebutate—Infection—Hydrocortisone—atopic dermatitis	0.000588	0.00106	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000581	0.00105	CcSEcCtD
Ingenol Mebutate—Eye disorder—Prednisone—atopic dermatitis	0.000579	0.00105	CcSEcCtD
Ingenol Mebutate—PRKCA—Downstream signaling in naïve CD8+ T cells—TNF—atopic dermatitis	0.000576	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—NGF—atopic dermatitis	0.000566	0.00168	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IFNG—atopic dermatitis	0.000559	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—MAPK8—atopic dermatitis	0.000558	0.00166	CbGpPWpGaD
Ingenol Mebutate—Infection—Triamcinolone—atopic dermatitis	0.000554	0.001	CcSEcCtD
Ingenol Mebutate—Infection—Methylprednisolone—atopic dermatitis	0.000553	0.000999	CcSEcCtD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL22—atopic dermatitis	0.00055	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	0.00055	0.00163	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000545	0.000986	CcSEcCtD
Ingenol Mebutate—Erythema—Prednisone—atopic dermatitis	0.00054	0.000976	CcSEcCtD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CCR3—atopic dermatitis	0.000539	0.0016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SELE—atopic dermatitis	0.000535	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL22—atopic dermatitis	0.000535	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—FCER1A—atopic dermatitis	0.000526	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCL27—atopic dermatitis	0.000525	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000523	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CXCL8—atopic dermatitis	0.00052	0.00154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by VEGF—IL6—atopic dermatitis	0.000519	0.00154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT6—atopic dermatitis	0.000515	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—STAT6—atopic dermatitis	0.000508	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ATF-2 transcription factor network—IL6—atopic dermatitis	0.000508	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TNF—atopic dermatitis	0.000506	0.0015	CbGpPWpGaD
Ingenol Mebutate—Infection—Dexamethasone—atopic dermatitis	0.000503	0.000908	CcSEcCtD
Ingenol Mebutate—Infection—Betamethasone—atopic dermatitis	0.000503	0.000908	CcSEcCtD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—MAPK8—atopic dermatitis	0.000502	0.00149	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CARD11—atopic dermatitis	0.000501	0.00149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL1B—atopic dermatitis	0.000498	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL2—atopic dermatitis	0.000497	0.00148	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000496	0.000897	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Betamethasone—atopic dermatitis	0.000496	0.000897	CcSEcCtD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000496	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CARD11—atopic dermatitis	0.000494	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL27—atopic dermatitis	0.00049	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCR3—atopic dermatitis	0.000489	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MS4A2—atopic dermatitis	0.000489	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IFNG—atopic dermatitis	0.000487	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—TAC1—atopic dermatitis	0.00048	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—NPS—atopic dermatitis	0.00048	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL27—atopic dermatitis	0.000477	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TNF—atopic dermatitis	0.000475	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000471	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SLC11A1—atopic dermatitis	0.000447	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000447	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—IL5—atopic dermatitis	0.000446	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL17—atopic dermatitis	0.00044	0.00131	CbGpPWpGaD
Ingenol Mebutate—Infection—Prednisone—atopic dermatitis	0.000438	0.000791	CcSEcCtD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—MAPK8—atopic dermatitis	0.000437	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NPS—atopic dermatitis	0.000436	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—TAC1—atopic dermatitis	0.000436	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—DEFB1—atopic dermatitis	0.000435	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NGF—atopic dermatitis	0.000435	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	0.000435	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL2—atopic dermatitis	0.000433	0.00129	CbGpPWpGaD
Ingenol Mebutate—Nervous system disorder—Prednisone—atopic dermatitis	0.000432	0.000781	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL17—atopic dermatitis	0.000427	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCR3—atopic dermatitis	0.000427	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—IL6—atopic dermatitis	0.000422	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	0.000409	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL5—atopic dermatitis	0.000406	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL5—atopic dermatitis	0.000405	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	0.000401	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—IL6—atopic dermatitis	0.000396	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—IL6—atopic dermatitis	0.000394	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—IL6—atopic dermatitis	0.000392	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—MAPK8—atopic dermatitis	0.000392	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KIF3A—atopic dermatitis	0.000392	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CASP1—atopic dermatitis	0.000391	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—IL6—atopic dermatitis	0.000391	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CASP1—atopic dermatitis	0.000385	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—GLB1—atopic dermatitis	0.000384	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000381	0.00113	CbGpPWpGaD
Ingenol Mebutate—Headache—Prednisolone—atopic dermatitis	0.00038	0.000686	CcSEcCtD
Ingenol Mebutate—Headache—Hydrocortisone—atopic dermatitis	0.000371	0.00067	CcSEcCtD
Ingenol Mebutate—PRKCD—Immune System—IL5—atopic dermatitis	0.00037	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—IL6—atopic dermatitis	0.000367	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—IL6—atopic dermatitis	0.000367	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—IL6—atopic dermatitis	0.000364	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TNF—atopic dermatitis	0.000362	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—IL6—atopic dermatitis	0.000361	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—IL6—atopic dermatitis	0.000359	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NFKBIA—atopic dermatitis	0.000359	0.00107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—MAPK8—atopic dermatitis	0.000358	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NFKBIA—atopic dermatitis	0.000356	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—MAPK8—atopic dermatitis	0.000355	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL11—atopic dermatitis	0.000354	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CMA1—atopic dermatitis	0.000354	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—TLR2—atopic dermatitis	0.000353	0.00105	CbGpPWpGaD
Ingenol Mebutate—Headache—Triamcinolone—atopic dermatitis	0.000349	0.000631	CcSEcCtD
Ingenol Mebutate—Headache—Methylprednisolone—atopic dermatitis	0.000348	0.00063	CcSEcCtD
Ingenol Mebutate—PRKCA—Innate Immune System—TLR2—atopic dermatitis	0.000348	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KIF3A—atopic dermatitis	0.000348	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCL10—atopic dermatitis	0.000346	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL11—atopic dermatitis	0.000345	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—FCER2—atopic dermatitis	0.00034	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT6—atopic dermatitis	0.000333	0.00099	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD79A—atopic dermatitis	0.000332	0.000987	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CCL5—atopic dermatitis	0.000328	0.000973	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	0.000325	0.000967	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CASP8—atopic dermatitis	0.000321	0.000955	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GLB1—atopic dermatitis	0.000321	0.000954	CbGpPWpGaD
Ingenol Mebutate—Headache—Betamethasone—atopic dermatitis	0.000317	0.000573	CcSEcCtD
Ingenol Mebutate—Headache—Dexamethasone—atopic dermatitis	0.000317	0.000573	CcSEcCtD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL22—atopic dermatitis	0.000316	0.000939	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—IL6—atopic dermatitis	0.000316	0.000938	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000314	0.000934	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.000311	0.000924	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCR3—atopic dermatitis	0.000309	0.000919	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ADSL—atopic dermatitis	0.000308	0.000915	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IL2—atopic dermatitis	0.000301	0.000893	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—IL6—atopic dermatitis	0.000298	0.000885	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCL5—atopic dermatitis	0.000297	0.000884	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT6—atopic dermatitis	0.000296	0.00088	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CCR5—atopic dermatitis	0.000295	0.000877	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—IL6—atopic dermatitis	0.000292	0.000867	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCR3—atopic dermatitis	0.000289	0.000858	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CARD11—atopic dermatitis	0.000288	0.000856	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL27—atopic dermatitis	0.000282	0.000837	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCR3—atopic dermatitis	0.000281	0.000835	CbGpPWpGaD
Ingenol Mebutate—Headache—Prednisone—atopic dermatitis	0.000276	0.000499	CcSEcCtD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—NPS—atopic dermatitis	0.000276	0.000819	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—TAC1—atopic dermatitis	0.000276	0.000819	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL18—atopic dermatitis	0.000272	0.000808	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00027	0.000803	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IL2—atopic dermatitis	0.00027	0.000802	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CCR5—atopic dermatitis	0.000268	0.000796	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD8A—atopic dermatitis	0.000268	0.000795	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CD4—atopic dermatitis	0.000264	0.000784	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NPS—atopic dermatitis	0.000258	0.000765	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TAC1—atopic dermatitis	0.000258	0.000765	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SLC11A1—atopic dermatitis	0.000257	0.000764	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL5—atopic dermatitis	0.000256	0.000762	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—IL6—atopic dermatitis	0.000255	0.000756	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—IL6—atopic dermatitis	0.000253	0.000752	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL17—atopic dermatitis	0.000253	0.00075	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCR3—atopic dermatitis	0.000253	0.00075	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—TAC1—atopic dermatitis	0.00025	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NPS—atopic dermatitis	0.00025	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—IL6—atopic dermatitis	0.00025	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	0.000246	0.000731	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCR3—atopic dermatitis	0.000246	0.00073	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—IL6—atopic dermatitis	0.000242	0.00072	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL5—atopic dermatitis	0.000239	0.000711	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	0.000235	0.000697	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—PPARA—atopic dermatitis	0.000233	0.000694	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL5—atopic dermatitis	0.000233	0.000692	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—IL6—atopic dermatitis	0.000228	0.000676	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—IL6—atopic dermatitis	0.000227	0.000673	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CCR5—atopic dermatitis	0.000226	0.000672	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—IL6—atopic dermatitis	0.000225	0.00067	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—MAPK8—atopic dermatitis	0.000225	0.000669	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KIF3A—atopic dermatitis	0.000225	0.000669	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CASP1—atopic dermatitis	0.000224	0.000667	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—IL6—atopic dermatitis	0.000224	0.000667	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—MAPK8—atopic dermatitis	0.000224	0.000664	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000219	0.000649	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL5—atopic dermatitis	0.000213	0.000632	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—IL6—atopic dermatitis	0.000211	0.000627	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—IL6—atopic dermatitis	0.000211	0.000627	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—IL6—atopic dermatitis	0.000209	0.000621	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NFKBIA—atopic dermatitis	0.000208	0.000617	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—IL6—atopic dermatitis	0.000207	0.000616	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—IL6—atopic dermatitis	0.000206	0.000613	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NFKBIA—atopic dermatitis	0.000205	0.000608	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL10—atopic dermatitis	0.000204	0.000607	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CMA1—atopic dermatitis	0.000204	0.000605	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL11—atopic dermatitis	0.000204	0.000605	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TLR2—atopic dermatitis	0.000203	0.000603	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL10—atopic dermatitis	0.000198	0.00059	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT6—atopic dermatitis	0.000191	0.000569	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD79A—atopic dermatitis	0.000191	0.000567	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCL5—atopic dermatitis	0.000188	0.000559	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CASP8—atopic dermatitis	0.000187	0.000556	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—IL6—atopic dermatitis	0.000187	0.000555	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CASP8—atopic dermatitis	0.000185	0.000549	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000181	0.000537	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000178	0.00053	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCL5—atopic dermatitis	0.000176	0.000522	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCL5—atopic dermatitis	0.000171	0.000508	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—IL2—atopic dermatitis	0.000171	0.000507	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CCR5—atopic dermatitis	0.000169	0.000504	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCR3—atopic dermatitis	0.000166	0.000493	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NGF—atopic dermatitis	0.000163	0.000484	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCL8—atopic dermatitis	0.000162	0.000481	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IFNG—atopic dermatitis	0.000159	0.000473	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCR5—atopic dermatitis	0.000158	0.00047	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL18—atopic dermatitis	0.000156	0.000464	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL2—atopic dermatitis	0.000155	0.00046	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL2—atopic dermatitis	0.000155	0.00046	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CCR5—atopic dermatitis	0.000154	0.000457	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD8A—atopic dermatitis	0.000154	0.000457	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD4—atopic dermatitis	0.000154	0.000457	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CD4—atopic dermatitis	0.000152	0.000451	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TAC1—atopic dermatitis	0.000148	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NPS—atopic dermatitis	0.000148	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCR3—atopic dermatitis	0.000145	0.000431	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—IL6—atopic dermatitis	0.000144	0.000427	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—IL6—atopic dermatitis	0.000143	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL1B—atopic dermatitis	0.000142	0.000422	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CD4—atopic dermatitis	0.000142	0.000422	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL2—atopic dermatitis	0.000141	0.00042	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL5—atopic dermatitis	0.000137	0.000409	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFKBIA—atopic dermatitis	0.000134	0.000399	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARA—atopic dermatitis	0.000134	0.000398	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MAPK8—atopic dermatitis	0.00013	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CCR5—atopic dermatitis	0.00013	0.000386	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MAPK8—atopic dermatitis	0.000128	0.000382	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFKBIA—atopic dermatitis	0.000119	0.000354	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL10—atopic dermatitis	0.000117	0.000348	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CASP8—atopic dermatitis	0.000108	0.00032	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARA—atopic dermatitis	0.000104	0.00031	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000102	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCL5—atopic dermatitis	0.000101	0.0003	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL2—atopic dermatitis	9.79e-05	0.000291	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL8—atopic dermatitis	9.57e-05	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NGF—atopic dermatitis	9.35e-05	0.000278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL8—atopic dermatitis	9.31e-05	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL2—atopic dermatitis	9.15e-05	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNG—atopic dermatitis	9.14e-05	0.000272	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL6—atopic dermatitis	9.1e-05	0.00027	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCR5—atopic dermatitis	9.09e-05	0.00027	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL2—atopic dermatitis	8.89e-05	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD4—atopic dermatitis	8.83e-05	0.000262	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAPK8—atopic dermatitis	8.42e-05	0.00025	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL6—atopic dermatitis	8.32e-05	0.000247	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—IL6—atopic dermatitis	8.2e-05	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL1B—atopic dermatitis	8.16e-05	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD4—atopic dermatitis	8.15e-05	0.000242	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL2—atopic dermatitis	8.13e-05	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFKBIA—atopic dermatitis	7.71e-05	0.000229	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—IL6—atopic dermatitis	7.68e-05	0.000228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MAPK8—atopic dermatitis	7.48e-05	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL8—atopic dermatitis	5.5e-05	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL6—atopic dermatitis	5.38e-05	0.00016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL2—atopic dermatitis	5.25e-05	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL6—atopic dermatitis	5.23e-05	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAPK8—atopic dermatitis	4.84e-05	0.000144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL6—atopic dermatitis	4.78e-05	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—IL6—atopic dermatitis	4.41e-05	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL6—atopic dermatitis	3.09e-05	9.18e-05	CbGpPWpGaD
